106 research outputs found
Biofertilizante agrobio: Uma alternativa no controle da mancha bacteriana em mudas de pimentão (Capsicum annuum l.)
Agrobio é um biofertilizante líquido fabricado à base de esterco bovino, água, melaço e sais minerais, que são submetidos a um processo de fermentação à temperatura ambiente por 56 dias em recipientes abertos. Este produto tem sido largamente utilizado com sucesso por agricultores orgânicos e convencionais em todo o estado do Rio de Janeiro, no controle de várias enfermidades vegetais em diferentes culturas. Em bioensaios realizados em casa de vegetação, observou-se uma ação bacteriostática equivalente a de produtos químicos comerciais contra Xanthomonas campestris pv. vesicatoria em mudas de pimentão (Capsicum annuum L.), numa concentração de 5%. Nos bioensaios in vitro, onde foram testadas as concentrações de 2, 5 10 e 50% do Agrobio comercial, observouse que, a partir da concentração de 5%, ocorreu um nível satisfatório de inibição do crescimento bacteriano, apesar deste ter sido inferior ao obtido com o uso de sulfato de cobre e sulfato
de estreptomicina
Efeito de produtos químicos e biológicos sobre a mancha bacteriana, flora microbiana no filoplano e produtividade de pimentão
Emprego de anticoncepcionais por uma população brasileira
A group of 245 married women from Mogi das Cruzes (State of S. Paulo, Brazil were questioned about the use of contraceptive practices, past obstetric history, child mortality, and attitude toward birth control. Answers were classified according to age and family earnings. Only 49% of these women practiced contraception, 42% of which used the "pill". There was a positive correlation between the practice of birth control and wage levels, and contraception was like-wise more common in the younger age groups. The natality was reduced considerably in those women who availed themselves of contraception and also it was observed a drastic decrease in the number of abortions and in child mortality. This effect was more pronounced in those who used the anovulatory drugs.Um grupo de 245 mulheres moradoras em Mogi das Cruzes (Estado de S. Paulo, Brasil) foi questionado com relação ao uso de anticoncepcionais, história obstétrica, mortalidade infantil e atitudes correlacionadas com a limitação da natalidade. As respostas foram classificadas segundo idade e nível de renda da informante. Apenas 49% das mulheres empregavam medidas anticoncepcionais, das quais 42% recorriam aos anovulatórios. Esta prática era mais freqüente entre as mulheres jovens, e aquelas pertencentes às famílias melhores situadas economicamente. Não só era mais baixa a natalidade nas mulheres que se valiam de anticoncepcionais, mas esta prática acompanhava-se de sensível redução no número de abortos e da mortalidade infantil. O efeito foi mais pronunciado entre aquelas que empregavam os anovulatórios
Red Propolis Antifungal Action on Species of Candida of the Oral Cavity
Introduction: propolis is a substance that has aroused the interest of many researchers because of its numerous therapeutic properties, antibacterial and antifungal.Objectives: identifying the species of Candida and evaluate the antifungal effect of red propolis yeast oral cavity.Method: this is a clinical in vitro study with saliva samples collected from 152 patients treated at the dental office of the Family Health Strategy in the city of São Bento-PB. The identification of Candida species was made through the Chrom Ãgar Candida. The antifungal activity of the propolis extract was analyzed in four different concentrations: 100%, 75%, 50% and 25%, through the agar diffusion test.Results: The most prevalent species was C. albicans; antifungal action as to the concentration of 25% of the propolis extract was that apparently demonstrated greater efficacy, compared to the highest concentration.Conclusion: The inhibitory effect of propolis against Candida may have been influenced by the concentration of alcohol present in the extract. To test this hypothesis suggests that search is performed with extracts of propolis and at the same time with the alcohol, in both concentrations and different environmental conditions. This study offers subsidies for other professionals employ different methodologies and propolis concentrations with other substances in order to test the antimicrobial action of these
Citalopram reduces aggregation of ATXN3 in a YAC transgenic mouse model of Machado-Joseph disease
Machado-Joseph disease, also known as spinocerebellar ataxia type 3, is a fatal polyglutamine disease with no disease-modifying treatment. The selective serotonin reuptake inhibitor citalopram was shown in nematode and mouse models to be a compelling repurposing candidate for Machado-Joseph disease therapeutics. We sought to confirm the efficacy of citalopram to decrease ATXN3 aggregation in an unrelated mouse model of Machado-Joseph disease. Four-week-old YACMJD84.2 mice and non-transgenic littermates were given citalopram 8 mg/kg in drinking water or water for 10 weeks. At the end of treatment, brains were collected for biochemical and pathological analyses. Brains of citalopram-treated YACMJD84.2 mice showed an approximate 50% decrease in the percentage of cells containing ATXN3-positive inclusions in the substantia nigra and three examined brainstem nuclei compared to controls. No differences in ATXN3 inclusion load were observed in deep cerebellar nuclei of mice. Citalopram effect on ATXN3 aggregate burden was corroborated by immunoblotting analysis. While lysates from the brainstem and cervical spinal cord of citalopram-treated mice showed a decrease in all soluble forms of ATXN3 and a trend toward reduction of insoluble ATXN3, no differences in ATXN3 levels were found between cerebella of citalopram-treated and vehicle-treated mice. Citalopram treatment altered levels of select components of the cellular protein homeostatic machinery that may be expected to enhance the capacity to refold and/or degrade mutant ATXN3. The results here obtained in a second independent mouse model of Machado-Joseph disease further support citalopram as a potential drug to be repurposed for this fatal disorder.This work was funded by Becky Babcox Research
Fund/pilot research award G015617, University of Michigan to M.C.C.
and NINDS/NIH R01NS038712 to H.L.P. The work performed at the
University of Minho was funded by the European Regional
Development Funds (FEDER), through the Competitiveness Factors
Operational Programme (COMPETE), and by National funds, through
the Foundation for Science and Technology (FCT), under the scope of the
project POCI-01-0145-FEDER-007038. This article was developed under the scope of the project NORTE-01-0145-FEDER-000013, supported
by the Northern Portugal Regional Operational Program (NORTE 2020),
under the Portugal 2020 Partnership Agreement, through the FEDER.
This work was also supported by FCT and COMPETE through the projects [PTDC/SAU-GMG/112617/2009] (to P.M.) and [EXPL/BIM-MEC/
0239/2012] (to A.T.C.); by FCT through the project [POCI-01-0145-
FEDER-016818 (PTDC/NEU-NMC/3648/2014)] (to P.M.); by National
Ataxia Foundation (to P.M. and to A.T.C.); and by Ataxia UK (to P.M.).
S.D.S. and A.T.C. were supported by fellowships from FCT, SFRH/BD/
78388/2011 and SFRH/BPD/102317/2014, respectively. FCT fellowships are co-financed by POPH, QREN, Governo da República
Portuguesa and EU/FSE
Methods and challenges for the health impact assessment of vaccination programs in Latin America
Protagonistas na sociedade civil: redes e centralidades de organizações civis em São Paulo
- …